VIPoma - Wikipedia
A VIPoma or vipoma (/ v ɪ ˈ p oʊ m ə /) is a rare endocrine tumor [1] that overproduces vasoactive intestinal peptide (thus VIP + -oma). The incidence is about 1 per 10,000,000 per year. VIPomas usually (about 90%) originate from the non-β islet cells of the pancreas .
VIPoma: Symptoms, Causes & Treatment - Cleveland Clinic
2024年12月3日 · VIPoma (vasoactive intestinal peptide secreting) tumors are rare. They develop in the endocrine cells in your pancreas. A VIPoma can be malignant (cancerous). The most significant symptom is severe watery diarrhea. Treatment may include medication to manage symptoms and surgery to remove the tumor. In some cases, surgery cures the disease.
ViPoma - StatPearls - NCBI Bookshelf
2023年6月12日 · Vasoactive intestinal peptide tumors (VIPoma) are neuroendocrine tumors secreting vasoactive intestinal peptide (VIP) in an unregulated manner. The VIPoma syndrome is also known as Verner-Morrison syndrome, watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria (WDHA) syndrome, and pancreatic cholera syndrome.
Vasoactive Intestinal Peptide-Secreting Tumor (VIPoma)
2023年4月5日 · A VIPoma is a neuroendocrine neoplasm secreting vasoactive intestinal peptide (VIP), usually presenting with severe watery secretory diarrhea, which can result in hypokalemia and metabolic acidosis and with flushes.
VIPoma: Clinical manifestations, diagnosis, and management
VIPomas are rare functioning neuroendocrine tumors that secrete vasoactive intestinal polypeptide (VIP) [1,2]. This topic will review the clinical manifestations, diagnosis, and management of VIPomas.
VIPoma - Symptoms, diagnosis and treatment | BMJ Best Practice …
2024年7月19日 · VIPoma is characterized by profuse watery diarrhea, hypokalemia, metabolic acidosis, and hypochlorhydria or achlorhydria, in the presence of elevated serum vasoactive intestinal peptide (VIP). VIPomas are highly malignant.
Vipoma - Endocrine and Metabolic Disorders - MSD Manuals
A vipoma is a non-beta pancreatic islet cell tumor secreting vasoactive intestinal peptide (VIP), resulting in a syndrome of watery diarrhea, hypokalemia, and achlorhydria (WDHA syndrome). Diagnosis is by serum VIP levels.
Vasoactive intestinal peptide secreting tumour: An overview
Vasoactive intestinal peptide (VIP) secreting tumour (VIPoma) is a rare functional neuroendocrine tumour that typically arises from pancreatic islet cells. These present as sporadic, solitary pancreatic neoplasias with an estimated incidence of one in ten million individuals per year.
Vipoma - Vipoma - MSD Manual Consumer Version
Vipomas are a type of pancreatic neuroendocrine tumor. More than half of these tumors are cancerous (malignant). In about 6% of people, vipoma occurs as part of a disorder called multiple endocrine neoplasia. The major symptom of vipoma is prolonged massive watery diarrhea.
VIPoma: MedlinePlus Medical Encyclopedia
2022年10月16日 · VIPoma causes cells in the pancreas to produce a high level of a hormone called vasoactive intestinal peptide (VIP). This hormone increases secretions from the intestines. It also relaxes some of the smooth muscles in the gastrointestinal system.